For this reason, even if a routine comprehensive haematological screening could be too expensive to be performed in all patients affected by hearing loss, audiologists should at least investigate patients presenting with SSNHL through coagulation tests and eventually assess them for genetic and acquired prothrombotic factors (such as the factor V Leiden and prothrombin mutations). The gene discussed is F5; the disease is hearing loss disorder.